VQV Signal
Healthleap secured $38 million in funding, including an $8M seed round and a $30M Series A, to develop AI that identifies hospital patients needing closer attention. The seed round was co-led by Sequoia Capital and First Round Capital, with Hummingbird Ventures leading the Series A.
Healthleap secured $38 million in funding, including an $8M seed round and a $30M Series A, to develop AI that identifies hospital patients needing closer attention. The seed round was co-led by Sequoia Capital and First Round Capital, with Hummingbird Ventures leading the Series A.
AI-assisted summary based on the listed source.
The financing includes an $8M seed round co-led by Sequoia Capital and First Round Capital, and a $30 million Series A led by Hummingbird Ventures.
This funding enables Healthleap to enhance AI tools that support clinical decision-making by flagging at-risk hospital patients. Improved patient monitoring can potentially lead to better outcomes and more efficient healthcare delivery.
Developers may have a new tool, API, or workflow change worth testing against their own stack.
VQV organizes public signals from inspectable sources. It does not independently verify the underlying report.
Signal Strength reflects source quality, relevance, freshness and evidence. Public Interest helps organize discovery; it is not proof of truth.
VQV surfaced this signal because it is recent, relevant to Startup Funding, connected to TechCrunch AI.
No login, cookies, social SDKs, or automatic posting.